123 related articles for article (PubMed ID: 38378357)
21. Association between micronutrients intake and metabolic-associated fatty liver disease: a cross-sectional study based on the National Health and Nutrition Examination Survey.
Hou JZ; Wu QW; Zhang L
J Nutr Sci; 2023; 12():e117. PubMed ID: 38033509
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China.
Liu D; Shen Y; Zhang R; Xun J; Wang J; Liu L; Steinhart C; Chen J; Lu H
J Gastroenterol Hepatol; 2021 Jun; 36(6):1670-1678. PubMed ID: 33140878
[TBL] [Abstract][Full Text] [Related]
23. Dietary and Lifestyle Inflammation Scores Are Inversely Associated with Metabolic-Associated Fatty Liver Disease among Iranian Adults: A Nested Case-Control Study.
Taheri E; Bostick RM; Hatami B; Pourhoseingholi MA; Asadzadeh Aghdaei H; Moslem A; Mousavi Jarrahi A; Zali MR
J Nutr; 2022 Feb; 152(2):559-567. PubMed ID: 34791370
[TBL] [Abstract][Full Text] [Related]
24. Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia/osteoporosis in T2DM patients.
Zhang W; Li Y; Li S; Zhou J; Wang K; Li Z; Chen N; Chen X
Front Endocrinol (Lausanne); 2023; 14():1278505. PubMed ID: 38116314
[TBL] [Abstract][Full Text] [Related]
25. Assessment of transient elastography in diagnosing MAFLD and the early effects of sleeve gastrectomy on MAFLD among the Chinese population.
Hu R; Wu B; Wang C; Wu Z; Zhang X; Chen X; Lu G; Yuan K
Int J Surg; 2024 Apr; 110(4):2044-2054. PubMed ID: 38215263
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study.
Chen YL; Li H; Li S; Xu Z; Tian S; Wu J; Liang XY; Li X; Liu ZL; Xiao J; Wei JY; Ma CY; Wu KN; Ran L; Kong LQ
BMC Gastroenterol; 2021 May; 21(1):212. PubMed ID: 33971822
[TBL] [Abstract][Full Text] [Related]
27. Associations of metal mixtures with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2003-2018.
Xie Z; Aimuzi R; Si M; Qu Y; Jiang Y
Front Public Health; 2023; 11():1133194. PubMed ID: 36950101
[TBL] [Abstract][Full Text] [Related]
28. Identification of Hepatic Dendritic Cells in Liver Biopsies Showing Steatosis in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Associated with Obesity.
Barranco-Fragoso B; Pal SC; Díaz-Orozco LE; Dorantes-Heredia R; Qi X; Méndez-Sánchez N
Med Sci Monit; 2022 Aug; 28():e937528. PubMed ID: 35934868
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of metabolic dysfunction-associated fatty liver disease using FibroScan, diet, and microbiota: A large cross-sectional study.
Tateda T; Iino C; Sasada T; Sato S; Igarashi G; Kawaguchi S; Mikami K; Endo T; Sawada K; Mikami T; Fukuda S; Nakaji S; Sakuraba H
PLoS One; 2022; 17(11):e0277930. PubMed ID: 36417462
[TBL] [Abstract][Full Text] [Related]
30. Associations of serum folate and vitamin C levels with metabolic dysfunction-associated fatty liver disease in US adults: A nationwide cross-sectional study.
Jiang Y; Cao H; Chen X; Yu G; Song C; Duan H; Tian F; Wan H; Shen J
Front Public Health; 2022; 10():1022928. PubMed ID: 36388270
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and risk factors of MAFLD and its metabolic comorbidities in community-based adults in China: A cross-sectional study.
He Y; Yao N; Tian F; Liu L; Lin X; Chen X; Duan H; Jiang Y; Yu G; Song C; Wang D; Ma Q; Liu L; Wan H; Shen J
Diabetes Metab Syndr; 2024 Mar; 18(3):102973. PubMed ID: 38493648
[TBL] [Abstract][Full Text] [Related]
32. An Observational and Cross-Sectional Study of the Prevalence of Breast Lesions and Metabolic Dysfunction-Associated Fatty Liver Disease and their Relationship in China.
Li S; Xu Z; Li H; Tang J; Liang XY; Tian S; Wu J; Li X; Liu ZL; Xiao J; Chen YL; Wei JY; Ma CY; Wu KN; Ran L; Kong LQ
J Gastrointestin Liver Dis; 2022 Mar; 31(1):31-39. PubMed ID: 35306559
[TBL] [Abstract][Full Text] [Related]
33. Sleep Factors in Relation to Metabolic Dysfunction-Associated Fatty Liver Disease in Middle-Aged and Elderly Chinese.
Yang J; Luo S; Li R; Ju J; Zhang Z; Shen J; Sun M; Fan J; Xia M; Zhu W; Liu Y
J Clin Endocrinol Metab; 2022 Sep; 107(10):2874-2882. PubMed ID: 35900115
[TBL] [Abstract][Full Text] [Related]
34. Metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease from clinical to pathological characteristics: a multi-center cross-sectional study in real world.
Li Y; Dai C; Ruan Y; Yang H; Zeng H; Huang R; Wang J; Dai M; Hao J; Wang L; Li J; Yan X; Lu Z; Ji F
Postgrad Med J; 2024 Apr; 100(1183):319-326. PubMed ID: 38272486
[TBL] [Abstract][Full Text] [Related]
35. Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population.
Moriyama K; Inoue N; Imai J; Masuda Y; Yamada C; Kishimoto N; Takashimizu S; Kubo A; Nishizaki Y
Metab Syndr Relat Disord; 2023 Nov; 21(9):489-496. PubMed ID: 37878804
[No Abstract] [Full Text] [Related]
36. Association between fatty liver index and controlled attenuation parameters as markers of metabolic dysfunction-associated fatty liver disease and bone mineral density: observational and two-sample Mendelian randomization studies.
Zeng L; Li Y; Hong C; Wang J; Zhu H; Li Q; Cui H; Ma P; Li R; He J; Zhu H; Liu L; Xiao L
Osteoporos Int; 2024 Apr; 35(4):679-689. PubMed ID: 38221591
[TBL] [Abstract][Full Text] [Related]
37. Association between self-reported snoring and metabolic-associated fatty liver disease: A cross-sectional analysis of the NHANES 2017-2018.
Wang Y; Shen R; Ge J
Sleep Med; 2023 Jan; 101():414-420. PubMed ID: 36516525
[TBL] [Abstract][Full Text] [Related]
38. Investigation about the correlation between the severity of metabolic-associated fatty liver disease and adherence to the Mediterranean diet.
Mokhtare M; Abdi A; Sadeghian AM; Sotoudeheian M; Namazi A; Khalighi Sikaroudi M
Clin Nutr ESPEN; 2023 Dec; 58():221-227. PubMed ID: 38057010
[TBL] [Abstract][Full Text] [Related]
39. The relationship between metabolic dysfunction-associated fatty liver disease and low muscle mass in an asymptomatic Korean population.
Seo JY; Cho EJ; Kim MJ; Kwak MS; Yang JI; Chung SJ; Yim JY; Yoon JW; Chung GE
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2953-2960. PubMed ID: 36222309
[TBL] [Abstract][Full Text] [Related]
40. Dietary Micronutrient Status and Relation between Micronutrient Intakes and Overweight and Obesity among Non-Pregnant and Non-Lactating Women Aged 18 to 49 in China.
Ju L; Wei X; Yu D; Fang H; Cheng X; Piao W; Guo Q; Xu X; Li S; Cai S; Zhao L
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
